Xerys Invest

Advanced BioDesign SAS is a contract research organization based in Saint-Priest, France, specializing in the discovery and production of biologics, particularly tailored biomolecules like antigens and antibodies. Founded in 2010, the company offers a diverse range of services, including the development of customized cell-based assays and kits, such as ELISA. Advanced BioDesign employs innovative technologies for analytical assessments, immune monitoring assays, and the quantification of bacterial contamination. The organization assists bio-industry clients throughout the development of their own research kits, providing support from feasibility studies to technology transfer. With a focus on oncology, infectious diseases, and neuroscience, Advanced BioDesign is also involved in the creation of novel anticancer drugs targeting specific pathways to combat tumor chemoresistance, thereby contributing to advancements in immunology and cancer therapy.

Biolog-id specializes in electronic identification and mobile data processing, focusing on the life sciences sector for over thirty years. The company develops comprehensive solutions for the identification and traceability of sensitive health products, such as blood products, chemotherapy treatments, and parenteral nutrition. By mastering communication protocols, including RFID technology, Biolog-id offers tailored interface programs to meet specific organizational needs. Its healthcare management platform transforms routine processes into actionable data, supporting both operational and strategic decision-making. The innovations developed by Biolog-id are protected by approximately seventy international patents.

Skytech is a French company founded in 2009 and based in Mantes-la-Jolie, specializing in the manufacturing of regenerated plastics. It serves various industries, including automotive, electrical and electronic devices, construction, household equipment, and sports. The company offers innovative recovery services for plastics, enabling manufacturers to recycle materials effectively. Skytech has developed a patented process known as TRIBLAST, which utilizes triboelectricity for recycling polymers, helping to give plastics a second life and contributing to the advancement of the circular economy.

Advanced BioDesign SAS is a contract research organization based in Saint-Priest, France, specializing in the discovery and production of biologics, particularly tailored biomolecules like antigens and antibodies. Founded in 2010, the company offers a diverse range of services, including the development of customized cell-based assays and kits, such as ELISA. Advanced BioDesign employs innovative technologies for analytical assessments, immune monitoring assays, and the quantification of bacterial contamination. The organization assists bio-industry clients throughout the development of their own research kits, providing support from feasibility studies to technology transfer. With a focus on oncology, infectious diseases, and neuroscience, Advanced BioDesign is also involved in the creation of novel anticancer drugs targeting specific pathways to combat tumor chemoresistance, thereby contributing to advancements in immunology and cancer therapy.

Sevenhugs Inc. specializes in ultra-wideband systems for indoor positioning and orientation tracking, providing innovative solutions for smartphone, IoT device, and automotive manufacturers. Founded in 2014 and based in San Francisco, the company is known for its Smart Remote, which serves as a universal remote control for televisions and smart home devices. This product simplifies the smart home experience by allowing users to control various devices—such as lights and music—through a single adaptive interface. Additionally, Sevenhugs offers features like secure localization, data fusion, and a low-power MAC protocol, enhancing its capabilities in access and security as well as location tracking. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.

Biolog-id specializes in electronic identification and mobile data processing, focusing on the life sciences sector for over thirty years. The company develops comprehensive solutions for the identification and traceability of sensitive health products, such as blood products, chemotherapy treatments, and parenteral nutrition. By mastering communication protocols, including RFID technology, Biolog-id offers tailored interface programs to meet specific organizational needs. Its healthcare management platform transforms routine processes into actionable data, supporting both operational and strategic decision-making. The innovations developed by Biolog-id are protected by approximately seventy international patents.

Herow is a technology company specializing in contactless solutions and location intelligence, providing a comprehensive platform for contextual marketing. The company integrates multi-technology solutions that enable clients to manage beacons, analyze real-time performance, and create customized reporting dashboards. Herow's offerings include Bluetooth Low Energy (BLE) beacons, near field communication beacons, and QR code beacons, alongside a software development kit (SDK) for mobile application design. Utilizing advanced geofencing and machine learning algorithms, Herow enhances user engagement by delivering hyper-precise location-based content tailored to individual behaviors and surroundings. This allows marketers and developers to gain insights into user interactions within smart city environments. Founded in 2007 and formerly known as Connecthings, Herow is headquartered in Paris with additional offices in New York, Rio de Janeiro, Barcelona, and Milan.

Datananas is a lead relationship management platform based in France, founded by Romain Simon. It offers a software-as-a-service solution that enables businesses to streamline their outbound sales efforts without the need for cold calling. The platform utilizes AI-powered technology to craft targeted and personalized email scenarios aimed at generating new leads. By automating these communications, Datananas facilitates a continuous flow of responses and appointments, allowing sales teams to efficiently manage their schedules and increase their appointment-setting capabilities.

Alzprotect is a biopharmaceutical company focused on developing drug candidates for the treatment of neurodegenerative diseases, particularly Alzheimer's disease and orphan tauopathies like Progressive Supranuclear Palsy. The company's research emphasizes the role of hyperphosphorylated Tau proteins and associated inflammation in neuronal degeneration. By advancing its drug candidates from discovery through clinical trials, Alzprotect aims to provide effective therapeutic options for conditions characterized by abnormal tau protein aggregation and related neurodegenerative processes.

Cryo Pur is a company based in Palaiseau, France, specializing in the design and manufacture of systems for cryogenic biogas upgrading and biomethane liquefaction. Founded in 2015, Cryo Pur's technology converts biogas from various sources, including agricultural, industrial, sewage sludge, and household waste, into two main products: liquid biomethane (bio-LNG) and liquid carbon dioxide (bioCO2). The company's systems are designed to improve the efficiency of biogas processing, catering to the needs of the cryogenic industry and contributing to sustainable waste management solutions.

Biolog-id specializes in electronic identification and mobile data processing, focusing on the life sciences sector for over thirty years. The company develops comprehensive solutions for the identification and traceability of sensitive health products, such as blood products, chemotherapy treatments, and parenteral nutrition. By mastering communication protocols, including RFID technology, Biolog-id offers tailored interface programs to meet specific organizational needs. Its healthcare management platform transforms routine processes into actionable data, supporting both operational and strategic decision-making. The innovations developed by Biolog-id are protected by approximately seventy international patents.

Sevenhugs Inc. specializes in ultra-wideband systems for indoor positioning and orientation tracking, providing innovative solutions for smartphone, IoT device, and automotive manufacturers. Founded in 2014 and based in San Francisco, the company is known for its Smart Remote, which serves as a universal remote control for televisions and smart home devices. This product simplifies the smart home experience by allowing users to control various devices—such as lights and music—through a single adaptive interface. Additionally, Sevenhugs offers features like secure localization, data fusion, and a low-power MAC protocol, enhancing its capabilities in access and security as well as location tracking. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.

Herow is a technology company specializing in contactless solutions and location intelligence, providing a comprehensive platform for contextual marketing. The company integrates multi-technology solutions that enable clients to manage beacons, analyze real-time performance, and create customized reporting dashboards. Herow's offerings include Bluetooth Low Energy (BLE) beacons, near field communication beacons, and QR code beacons, alongside a software development kit (SDK) for mobile application design. Utilizing advanced geofencing and machine learning algorithms, Herow enhances user engagement by delivering hyper-precise location-based content tailored to individual behaviors and surroundings. This allows marketers and developers to gain insights into user interactions within smart city environments. Founded in 2007 and formerly known as Connecthings, Herow is headquartered in Paris with additional offices in New York, Rio de Janeiro, Barcelona, and Milan.

APR2, established in 2002, specializes in the collection and recycling of waste electrical and electronic equipment (WEEE). The company addresses the significant challenge posed by large volumes of plastic waste from discarded monitors, printers, and computers, which traditionally faced disposal through burial or incineration. To combat the environmental impact of such waste, APR2 has invested heavily in research and development to create advanced industrial sorting and recycling solutions. Through its innovative platform, APR2 focuses on the recovery, processing, and reuse of industrial plastic and electronic waste, promoting sustainable practices among industry players and encouraging the use of recycled materials. This approach not only helps reduce raw material consumption but also supports a broader commitment to eco-design and sustainable development.

PowiDian specializes in the development of autonomous power stations that provide reliable, non-polluting electricity regardless of location or weather conditions. Their flagship product, the SAGES® station, operates independently of fossil fuels and requires minimal maintenance, typically only once a year. This innovative station integrates various renewable energy sources, including wind, solar, geothermal, and marine energy, along with advanced energy storage solutions such as lithium-ion batteries for short-term needs and hydrogen storage for long-term use. Additionally, PowiDian employs sophisticated simulation and predictive software to optimize the performance of its systems. By offering green energy and hybrid alternatives, PowiDian enables clients to access electricity at a low cost while minimizing environmental impact.

PowiDian specializes in the development of autonomous power stations that provide reliable, non-polluting electricity regardless of location or weather conditions. Their flagship product, the SAGES® station, operates independently of fossil fuels and requires minimal maintenance, typically only once a year. This innovative station integrates various renewable energy sources, including wind, solar, geothermal, and marine energy, along with advanced energy storage solutions such as lithium-ion batteries for short-term needs and hydrogen storage for long-term use. Additionally, PowiDian employs sophisticated simulation and predictive software to optimize the performance of its systems. By offering green energy and hybrid alternatives, PowiDian enables clients to access electricity at a low cost while minimizing environmental impact.

APR2, established in 2002, specializes in the collection and recycling of waste electrical and electronic equipment (WEEE). The company addresses the significant challenge posed by large volumes of plastic waste from discarded monitors, printers, and computers, which traditionally faced disposal through burial or incineration. To combat the environmental impact of such waste, APR2 has invested heavily in research and development to create advanced industrial sorting and recycling solutions. Through its innovative platform, APR2 focuses on the recovery, processing, and reuse of industrial plastic and electronic waste, promoting sustainable practices among industry players and encouraging the use of recycled materials. This approach not only helps reduce raw material consumption but also supports a broader commitment to eco-design and sustainable development.

Advanced BioDesign SAS is a contract research organization based in Saint-Priest, France, specializing in the discovery and production of biologics, particularly tailored biomolecules like antigens and antibodies. Founded in 2010, the company offers a diverse range of services, including the development of customized cell-based assays and kits, such as ELISA. Advanced BioDesign employs innovative technologies for analytical assessments, immune monitoring assays, and the quantification of bacterial contamination. The organization assists bio-industry clients throughout the development of their own research kits, providing support from feasibility studies to technology transfer. With a focus on oncology, infectious diseases, and neuroscience, Advanced BioDesign is also involved in the creation of novel anticancer drugs targeting specific pathways to combat tumor chemoresistance, thereby contributing to advancements in immunology and cancer therapy.